LuvHerbsHerbal Passion
Natural Herbal Female Libido Enhancers & Female Aphrodisiacs
for Herbal Female Orgasm, Female Pleasure, and Female Sexual Satisfaction
 

www.female-libido-enhancers.net
 
 
Where to Buy Tribulus          Contact Us
 

  Home
  Contact Us
  Where To Buy Tribulus
  Female Libido Herbal Enhancers
  Female Libido News
  Libido Terms Dictionary
  Testosterone Female Libido
  Herbs Restore Hair
  Female Sexual Dysfunction
  Widespread
  Tribulus Helps Menopause
  Symptoms
  FE Herbal Medicine Directory
  Real Estate Directory Female
  Libido Enhancers
  FE Real Estate Directory
  Links
 Home Remedies:
 
 
Allergy Home Remedy Recipes
 Asthma Home Remedy Recipes
 
High Blood Pressure
     (Hypertension)

 Sinus Health Home Remedies
 
 Female Libido Enhancer
Attention Ladies: Increase your
 sexual
libido and orgasmic capability
 by taking
two tablets per day (one
 with breakfast
and one with dinner) of
 Tribulus
Terrestris, available for your
 
purchase at an affordable price at
 Female Libido
Enhancers. Take one
 tablet with one
full glass of water at
 breakfast and
again at dinner.
 
 Erectile Dysfunction Herbal
 Remedies

 Stop erectile dysfunction and erection
 problems from hurting your love life by
 taking the following erection pills two
 hours
before sexual activity: (1) one
 tablet of Tongkat Ali; (2) one
tablet of
 Tribulus Terrestris; and (3) two

 
tablets of Arginine. Take with with one
 full glass of water at meal time.  You
 can buy all three herbal sex enhancers
 at an affordable price at Male Erection
 Problems.

 
 Where To Buy Tongkat Ali for
 FREE
Worldwide Postal
Delivery

 Buy USA Tongkat Ali, the most
      effective and safest herbal
      remedy for erectile dysfunction.
  ►Buy Philippines Tongkat
      Ali        
  ►Buy Tongkat Ali Worldwide
      Postal Delivery.
 
   Recommended LuvHerbs™
   Dosage:

 
 ►Tribulus to increase female sex
     libido:
Take one Tribulus tablet
     twice per day, everyday at
     breakfast and at dinner.
 ►Strong Erection Combo for men:
 
   ♥
To be ready at any time for
      daily sex,
take one each of
      Tribulus, Tongkat ali, & Arginine
      at breakfast & again at dinner.
 
   ♥
To be ready for sex on a less
      frequent basis,
take two each of
      Tribulus, Tongkat ali, & Arginine
      two to three hours in advance of
      sexual activity.
 Visit LuvHerbs™ Websites Info
 on Herbal Remedies for Erectile
 Dysfunction & Decreased Female
 Libido.
 
Female Libido Enhancers
 Erectile Dysfunction
Tongkat Ali for Erection
Tribulus for Erectile Dysfunction

Real Estate Directory

 
 Be trained online and designated as a
 Certified Herbalist for only US$
 500
and attract many clients by being
 listed in the Certified Herbalists
 Directory.
 
 Read Tongkat Ali scientific studies.
 Be certified and designated as a
 Certified Massage Therapist.
 
 Also visit our other effective
 websites listed below:
     Real Estate Websites:
 

     Bacolod Real Estate
    
Cebu Home
    
Cebu House
     Cebu Real Estate
     Davao Real Estate
     Dumaguete Home
     Dumaguete House
     Dumaguete Real Estate
     International Real Estate
     Kota Kinabalu Real Estate
     Negros Island Real Estate
     Philippine Real Estate
     Sabah Real Estate For Sale
 
     Business Websites:
 

     Asset Protection
     Business English
     Business Trust
     Business Trust Formation
     Estate Planning
     International Business Trust
     Income Tax Planning
     Living Trust
     Offshore Tax Planning
     Philippine Businesses For Sale
     Tax Accountant
      Tax Consultant
     Tax Education
     Tax News
     ● Tax School
     Where to Buy Business Directory
 
     Environmental Websites:
 
     Black Mold House   
    
Black Mold Picture
     Black Mold Symptom    
    
Black Toxic Mold
     Certified Hygienists
     Environmental Hygienist
    
Mold
     Mold Inspector
     Mold Remediation
     Mold Training
      Occupational Hygienists
 
     Health Websites:
 
     Bacolod Massage
     Certified Herbalists Directory
     Dumaguete Massage
     Erectile Dysfunction
     Herb Sex Boosters
     Live Longer
     Longevity
     Massage School
     Massage Therapy Training
    
Massage Therapy School
    
Massage Therapy Certification
     Philippines Massage
     Sex News
     Tongkat Ali for Erection
     Tribulus terrestris for Erectile
        Dysfunction
 
      Construction Websites:
 

      Bacolod Construction
      Bacolod Home Builder
      Cebu Construction
      Cebu Home Builder
      Davao Construction
      Davao Home Builder 
      Dumaguete Construction
      Dumaguete Home Builder
      Manila Construction
      Manila Home Builder
 
          Hotel Websites:
 

       Dumaguete Apartment      
      
Dumaguete Apartments

       Dumaguete Hotels  
       Dumaguete House For Rent
       Dumaguete Hotel Reservation
       Dumaguete Hotel Room
       Philippines Honeymoon
 

 
 
Tribulus Treats Menopausal Syndrome Symptoms
 
 This study reports that "The opinion of the research team, based on the experience
 from treatment of more than 150 women with natural or postoperative menopause,
 is that Tribulus can successfully be used for treatment of the menopausal syndrome
 in women."

 
 Clinical Studies on Tribulus terrestris Protodioscin in Women
 with Endocrine Infertility or Menopausal Syndrome
 
 P. Tabakova, M. Dimitrov, B. Tashkov
 First Obstetrical and Gynecological Hospital “T. Kirkoua” – Sofia, Bulgaria
 IIMS Therapeutic Focus

 
 Summary: The opinion of the research team, based on the experience from
 treatment of more than 150 women with natural or postoperative menopause, is
 that Tribulus can successfully be used for treatment of the menopausal syndrome in
 women. Tribulus treatment resulted in the complete or almost complete
 disappearance of all or most of the menopausal syndrome symptoms were found in
 49 from 50 treated patients (98%).  The study also noted that Tribulus restores
 and improves libido sexualis in men, improves and prolongs the duration of
 erection, and also that Tribulus exerts a stimulating influence on spermatogenesis
 by increasing the number of spermatozoa and their mobility. It increases the level
 of testosterone.

 The therapeutic effect of Tribulus terrestris' protodioscin on the endocrine function
 of women was studied by the team in the last few years. The first clinical trials were
 carried out on women with the dysovulatory syndrome and infertility and later they
 were redirected to the premenopausal and menopausal syndrome. Women with
 postoperative castration-induced menopause were included in a separate group.

 Materials and methods
 

 The Tribulus terrestris extract in the form of 250 mg film tablet containing the
 superterrestrial part of the plant with a predominant content of protodioscin.
 Control experiments were performed with placebo tablets of the same commercial
 appearance.

 Regimens of application
 Group A – women with dysovulatory disorders and infertility.

 - Regimen recommended by the producer: 1-2 tablets 3 times daily for a period of
 2 to 3 months.
 - Our regimen 3x1 tablets up to 3x2 tablets daily from the 5th to the 14th day of
 the menstruation cycle for a total period of 2-3 months.
 - After follow-up of a set of parameters to evaluate the integral effect of the
 Tribulus preparation only the regimen is switched over to combined therapy with
 Tribulus and hormonal preparation to stimulate ovulation:

 1. Tribulus according to the second regimen and Stimobul (Organon) 1-2 tablets
 from the 5th to the 14th day of the cycle for 3 months total.
 2. Tribulus according to the second regimen and Clostylbegit (Hungary) 1-2 tablets
 daily from the 5th to 9th day of the cycle for 3 months.

 Group B – women with menopausal syndrome.
 - Tribulus at 3x2 tablets for 20 days and tapering the dosage by 1 tablet every 4-5
 days to come down to the maintenance dose of 2x1 tablets per day for a total
 period of time strictly individualized depending on the degree of the effect obtained.
 - Tribulus at 2x2 tablets for 30 days with subsequent reduction in the dosage every
 4-5 days to 2x1 tablets daily.
 - Tribulus at 3x1 tablets continuously for a long period of time (up to 1 year).
 
 
Clinical contingent
 Group A – 51 women with diagnosed primary and secondary endocrine infertility
 treated in the First Gynecological Hospital “T. Kirkova”, Sofia, from 1984 to
 1984. Fifteen of these women were treated by the first regimen and 36 by the
 second regimen After a 3-month period of observation, the combined therapy of
 the third regimen was used on 20 of these women. Parallel control studies on a
 comparable contingent were carried out with hormone preparations: Stimovul
 (Organon) on 62 women; Clostylbegit (Hungary) on 21 women, Fertodur
 (Schering) on 29 women. The total number of women covered by the study was
 163.

 Group B – 50 women with diagnosed natural or post-castration menopausal
 syndrome treated in the period 1986 to 1987. A pilot study with 12 more women
 was carried out in 1984. In 46 of 50 women (92%), immediately after verifying the
 diagnosis and the degree of manifestation of the clinical picture of menopause, we
 initiated treatment with placebo of 3x2 tablets daily for a total period of 15 to 30
 days. After having registered the effect of placebo, we continue with the Tribulus
 therapy using the above regimens.

 Parameter of observation and recording

 For the clinical contingent of Group A
 The final result from the treatment was classified in 3 types: normalization of
 ovulation with subsequent pregnancy, normalized ovulation without pregnancy; and
 no effect. The following parameters were recorded: subjective sensations (changes)
 in general conditions and libido sexualis; onset and duration of menstruation; basal
 temperature; hormonal vaginal cytopreparations; pregnandiol, 17-KC and 17-OH-
 KC in the urine histological changes in the endometrium; echographic
 folliculometry; radio immunological control of gonadotropic and steroid production;
 hysterosalpingographs and laparoxopy to determine the state of the fallopian tubes
 and their elimination, as far as possible as causes of infertility.
 
 For the clinical contingent of Group B
 The results of treatment were classified depending on the clinical picture as
 complete disappearance of menopausal complaints; great decrease of the former;
 and no effect on complaints.
 
 
The following parameters in the nervous vegetative and neuro-psychic complaints
 intensity and frequency of the hot flashes and sweating, depression or
 superexcitation, easy fatigueability, apathy, etc.; changes in the cardiovascular
 system including changes in pulse and blood pressure, oppression in the heart
 region, tachycardia or extrasystoles, etc.; micturition disorders, pruritus in the
 external genitalia; hormonal cytopreparations; blood count and blood sugar profile;
 ultrasonic diagnostics; radioimmunological control of gonadotropic and steroid
 hormones; as well as libido sexualis.

 Results and discussion

 Group A
 Fifteen patients were treated by the first regimen, none of them showed any
 essential changes in parameters determining the occurrence of ovulation. Moreover,
  there were noted some undesirable effects such as a longer menstruation cycle,
 excessive libido sexualis, related general excitability, insomnia, and in case of
 abrupt discontinuation of the drug intake at the end of the third month or even in
 reducing the dose by 50% only – a dramatic decrease of libido sexualis and
 general weakness. It made necessary to apply the second regimen to the remaining
 36 patients – the date are down in the following figures and tables. The distribution
 of women treated with Tribulus is given on Figure 1. The prevailing number of them
 were in the age group 28 to 30 years old and only 2 were over 36 years of age.
 Nineteen patients were with primary hormonal infertility and 18 with secondary
 hormonal infertility, i.e. the number was almost equal, see Figure 2. The distribution
 of patients with regard to previous treatment is shown on Figure 3. One can note
 that those untreated previously were about 36% of the women: others with prior
 hormonal or surgical correction of ovaries were of almost the same number – 20 to
 30% and the smallest was the group with combined hormonal and surgical therapy.
 In Table 1 we show lower values of unsatisfactory treatment with Tribulus (33.3%) compared to Clostylbegit (52.4%) or Fertodur (76%). Undoubtedly best results
 were obtained with Stimovul normalized ovulation with subsequent pregnancy of
 39%, normalized ovulation without resultant pregnancy of 35.5% and no effect of
 26%. Tribulus has a considerably more moderate effect: 24 of the total number of
 36 treated women had normalized ovulation but only in 2 of them was followed by
 pregnancy and in 12 patients it had no basic effect. Twenty women were treated
 simultaneously with Tribulus and an ovulation stimulant. The effect from their
 combined use was better compared to treatment with single agents. Probably here
 there is a complex effect – hormonal stimulation of ovulation is combined with
 increased libido sexualis and improved general and psyche-emotional condition of
 the infertile couple particulary taking into account the fact that we recommend the
 use of Tribulus also to the husbands. No side effects were observed in the
 intermittent application of Tribulus.

Age distribution of female patients treated with protodioscin
Figure 1

Age distribution of female patients treated with protodioscin
Figure 2

Distribution of female patients treated with protodioscin by preceding
hormonal, surgical, or combined therapy
Figure 3

  Affordable Health Products for Sale:
 
  ● Buy Sex Toys online
 
● Buy Herbal Books
  ● Buy Health DVD's

  ● Buy Herbal Supplements for your health.
  ● Buy Health and Sex Pills.
  ● Buy Herbal Lotions and Herbal Moisturizers for your daily use.
 

Comparative data on the effect of Tribulus, Stimovul, Clostybegit, Fertodur on females with endogenous infertility
Table 1

Group by method of treatment

Number

Therapeutic results

Normalized ovulation with pregnancy

Normalized Ovulation no pregnancy

No effect

Side effects

Treated with Tribulus terrestris

36

2 (5.6%)

22 (61.1%)

12 (33.3%)

-

Treated with Stimovul

62

24 (38.7%)

22 (35.5%)

16 (85.8%)

4 (6.5%)

Treated with Clostylbegit

21

4 (19.0%)

6 (28.6%)

11 (52.4%)

8 (38.1%)

Treated with Fertodur

29

2 (6.9%)

5 (17.2%)

22 (75.9%)

3 (10.6%)

Total

148

32

55

61

15

 Group B
 
The age distribution of the patients in this group is represented on Table 1. Only four of them are younger than 40 years and
 2 over 60 years of age. Eighty percent of all treated women are in the age group 40 to 55.

 Twenty six patients were with the natural onset of menopause and the remaining 24 (48%) – postoperative castration
 climacteric (Table 2). The duration of the menopausal syndrome is shown on Table 3. As seen in a considerable part of
 patients the menopause dated back on the year prior to therapy with Tribulus. Those were mainly women with postoperative
 menopause.

Distribution of patients by age
Table 1

Age Group (yrs)

Number of patients

Percent

30-34

1

2.0

35-39

3

6.0

40-44

8

16.0

45-49

19

38.0

50-54

13

26.0

55-59

4

8.0

60

2

4.0

Total

50

100.0

Effect of Tribulus during menopause distribution of patients by type of menopause
Table 2

Type of menopause

Number of patients

Percent

Natural

26

52.0

Postoperative

24

48.0

Total

50

100.0

Distribution of patients by duration of menopause
Table 3

Duration of menopause (months)

Number of patients

Percent

< 12

19

38.0

12 - 35

16

32.0

36 - 60

7

14.0

> 60

8

16.0

Total

50

100.0

 The clinical picture of the menopausal syndrome in the group under study was predominated by several major symptoms
 represented diagrammatically on Tables 4 and 5.

Effect of protodioscin during menopause distribution of patients by incidence of some symptoms before treatement
Table4

Symptoms

Number of patients

Percent

Hot flashes

50

100

Perspiration

39

78

Depression

27

54

Hyperexcitation

22

44

Sleeplessness

41

82

Tenseness

18

36

Feeling of heaviness

30

60

RR-changes

11

22

ECG-changes

8

16

Distribution of patients by type of libido sexualis
Table 5

Type of libido sexualis

Number of patients

Percent

Normal

2

4.0

Low

20

40.0

Very low

28

56.0

Total

50

100.0

 Nervous vegetative manifestations were quite frequent with all treated women. The hot flash was present in 100% of women,
 sweating in 78%, insomnia in 82%, and unmotivated superexcitation in 44%.

 From the cardiovascular changes, the heaviness in the heart region was predominant (60%) and changes in the blood
 pressure and ECG were observed in 16 women (22%). Libido sexualis was unchanged in only two women (in comparison
 with the previous state) greatly decreased to completely lost desire for sexual contacts were characteristic to 56% of all
 patients.

 It should be noted that the intake of placebo tablets by 46 from 50 women did not result in a favorable effect on any
 complaint (Table 6)

                                                  Distribution of patients by duration of placebo treatment
                                                                                   Table 6

Duration of treatment (days)

Number of patients

Percent

0

4

8.0

14

6

12.0

15 - 20

32

64.0

21 - 30

8

16.0

Total

50

100.0

 According to the selected signs for classification we established, complete or almost complete disappearance of all or most
 of the symptoms were found in 49 from 50 treated patients (98%). Only in one woman did Tribulus not have an effect on the
 menopausal syndrome and she was transferred to other treatments. Table 7 shows that in 50% of the treated women the
 course of treatment needed not less than 110 up to 180 tablets to achieve favorable effect. In 10% of the women this dose
 was even higher – 190 to 220 tablets. The average effective doses are given in Table 8 and in the greater number of women
 those were more than 100 tablets per course of treatment. The effect obtained was retained by a maintenance dose of 2 to 3
 tablets a day in 84% of the treated women (Table 9).

Distribution of patients by the total effective dose of protodioscin
Table 7

Total number of tablets

Initial dose (tablets / day)

3x1

2x2

3x2

Total

No.

%

No.

%

No.

%

No

%

< 60

2

4

-

-

-

-

2

4

60 - 100

5

10

5

10

8

16

18

36

110 - 180

-

-

7

14

18

36

25

50

190 - 220

-

-

1

2

1

2

2

4

> 220

-

-

-

-

3

6

3

6

Total

7

14

13

26

30

60

50

100

Total effective dose of protodioscin
Table 8

Dose (tablets/day)

Number

Total effective dose

Mean

Limit of confidence (mean+1.96 SEM)

3 x 1

7

68.6

53.0 - 84.2

2 x 2

13

115.4

93.7 - 137.1

3 x 2

30

141.5

113.7 - 169.3

                                               Distribution of patients by the supporting dose of protodioscin
                                                                                         Table9

Supporting dose (tablets/day)

Number of patients

Percent

2 x 1

27

55.1

3 x 1

14

28.6

2 x 2

8

16.3

Total

49*

100.0

*1 patient without effect

 

 

 The dynamic cytological monitoring of the progesterone – estrogen level (vaginal cytopreparation) showed that only in 14%
 of the patients there was present a high initial level of estrogen, while in 44% of them it was low or very low (Table 10).

Distribution of patients by level of progesterone/estrogen according to hormonal cytological examination
Table 10

Level

Number of patients

Percent

High

7

14

Normal

1

2

Low

6

12

Very low

16

32

Total

30*

100

* 20 patients without cytological examination

 The particularly strict radioimmunological monitoring is shown on Table 11 and Table 12.

Effect of protodioscin during menopause radioimmunoassays
Table 11

Hormone

Protodioscin treatment

Number

Limit of confidence (mean + 1.96 SEM)

FSH

Before

46

51.38 + 72.34

 

After

42

42.30 + 59.74

LH

Before

42

32.45 + 46.05

 

After

43

29.62 + 38.28

Prl

Before

42

265.20 + 378.20

 

After

37

200.60 + 267.60

E2

Before

43

0.2 + 0.22

 

After

40

0.2 + 0.54

Prg

Before

32

5.0 + 10.3

 

After

34

4.14 + 7.44

Tst

Before

41

1.15 + 1.74

 

After

45

0.96 + 1.30

 The variance analysis showed that both the mean values and the confidence interval are within the limits normal to the age.
 Comparison of these data prior to and after therapy showed that gonadotropic hormones levels decreased compared to the
 initial values, while the ovarian hormones did not demonstrate such a decrease. There was even an insignificant increase
 especially in the E2 hormone. These data together with the clinical picture can account for the favorable influence on the
 menopausal complaints and the considerably enhanced libido sexualis in two-third of the treated women.

 In this case the effect of Tribulus is equivalent, and in some cases even better than, that of the estrogen-testosterone
 hormonal preparation Ambosex without the adverse side effect of the latter such as virilization and tendency for weight gain.

 Side effect in treatment with Tribulus
 Nausea, vomiting, allergy phenomena, and intolerance were not observed. The preparation is well tolerated. It is worthwhile
 to note the fact that after achieving the desireable effect the abrupt decrease in the effective dose down to the maintenance
 dosage results in the sudden and complete unlocking of almost the whole menopausal symptom complex. Therefore, the
 transition from the effective dose to the maintenance dose should be gradual and for a longer period of time.

 Conclusion
 Our long-term experience with the use of the preparation Tribulus for treatment of infertility mainly in women, but quite
 frequently in men as well, make us recommend it for disturbed gamete formation due to stress situations, long years of
 infertile marital life, impaired or almost missing libido sexualis, leading to anovulatory menstruation cycles, dyskinetic changes
 of fallopian tubes and qualitative changes in the sperm.

 A combination of Tribulus with suitable hormone preparations results in potentiating its positive effect which explains its use
 in everyday practice for treatment of infertility in the family.

 The opinion of the research team, based on the experience from treatment of more than 150 women with natural or
 postoperative menopause, is that Tribulus can successfully be used for treatment of the menopausal syndrome in women.

 Tribulus
 Composition: a natural product, obtained from the overground part of the plant Tribulus terrestris, containing mainly saponins
 of the furostanol type with a predominant quantity of protodioscin (no less than 45%).

 Action: non-hormonal preparation which restores and improves libido sexualis in men, improves and prolongs the duration
 of erection. It exerts a stimulating influence on spermatogenesis by increasing the number of spermatozoa and their mobility.
 It increases the level of testosterone.

 It improves libido sexualis in women, exerts a slight stimulating ovulation effect, it has a favorable influence on vasomotory
 manifestation during natural and post-castration climacterium, as well as on subjective complains such as insomnia, general
 tenseness, irritability or apathy, etc.

 Indication: in men – impotentia coeundi in Klinefelter’s syndrome, varicocele, Cryptorchism, hypotrophy of testicles,
 syndrome of Noonan, sterility on the basis of idiopathic oligoasthenozoospermia idiopathic azoospermia, varicocele.

 In women – endocrinous ovarian sterility, climacteric and post-castration syndrome with expressed vasomotory and
 neurasthenic manifestations.

 Contraindication – none

 Application: in men – the dosage and duration of treatment are determined according to the character and gravity of
 disease. Most often, the dose is 1 to 2 tablets 3 times a day during meals. The treatment duration is as follows: in case of
 impotential coeundi: 40 to 50 days at least in sterility 70 to 90 days.

 In women, the treatment is strictly individual and depends on the gravity of manifestations. The dose most often used here is
 also 1-2 tablets 3 times a day during meals. In cases of sterility the preparation is applied from the first to the twelveth days
 of the menstruation cycle. In postcastration and climacteric syndrome the treatment lasts 60 to 90 days. After an
 improvement is obtained the dose is reduced to 2 tablets daily for another 50 to 60 days as supporting dose.